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Background: Adjusted clinical groups (ACG®) have been widely used to adjust resource distribution; however, the
relationship with effectiveness has been questioned. The purpose of the study was to measure the relationship
between efficiency assessed by ACG® and a clinical effectiveness indicator in adults attended in Primary Health Care
Centres (PHCs).
Methods: Research design: cross-sectional study. Subjects: 196, 593 patients aged >14 years in 13 PHCs in Catalonia
(Spain). Measures: Age, sex, PHC, basic care team (BCT), visits, episodes (diagnoses), and total direct costs of PHC
care and co-morbidity as measured by ACG® indicators: Efficiency indices for costs, visits, and episodes (costs EI,
visits EI, episodes EI); a complexity or risk index (RI); and effectiveness measured by a general synthetic index (SI). The
relationship between EI, RI, and SI in each PHC and BCT was measured by multiple correlation coefficients (r).
Results: In total, 56 of the 106 defined ACG® were present in the study population, with five corresponding to
44.5% of the patients, 11 to 68.0% of patients, and 30 present in less than 0.5% of the sample. The RI in each PHC
ranged from 0.9 to 1.1. Costs, visits, and episodes had similar trends for efficiency in six PHCs. There was moderate
correlation between costs EI and visits EI (r = 0.59). SI correlation with episodes EI and costs EI was moderate (r = 0.48
and r = −0.34, respectively) and was r = −0.14 for visits EI. Correlation between RI and SI was r = 0.29.
Conclusions: The Efficiency and Effectiveness ACG® indicators permit a comparison of primary care processes between
PHCs. Acceptable correlation exists between effectiveness and indicators of efficiency in episodes and costs.
Keywords: Adjusted clinical groups (ACG®), Case-mix system, Efficiency, Effectiveness, Risk indicators, Primary health careBackground
Patient classification systems were introduced more than
20 years ago in order to measure patient characteris-
tics. Of those developed for the hospital environment,
Diagnosis Related Groups (DRG) are the most widely
reported and used internationally [1]. However, in the
primary health care centre (PHC) setting many aspects of
these patient classification systems instruments are still
in the research phase. Nonetheless, they are beginning to
be used in some Spanish regions as an aid to clinical* Correspondence: cviolan@idiapjgol.org
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reproduction in any medium, provided the ordecision-making, health resource planning, resource distri-
bution and epidemiological research, as they allow more
reliable and accurate comparisons between physicians than
do population characteristics alone [2-4].
Adjusted Clinical Groups (ACG®) [5] is the most widely
used of the systems developed for the PHC setting. In this
context, age is the variable normally used to adjust re-
source distribution. However, type of disease may explain
half of the variability in the use of resources, measured
by frequency (visits or contacts), indirect use (referrals
to specialists), and direct costs (diagnostic tests, analyses
and drug prescriptions) [6-8].
The Johns Hopkins ACG® System [9] has developed
new methodologies to categorize disease types which are
closer to the global conception of health status held bytd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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disease may play in resource utilization and clinical man-
agement. In addition, predictive models of utilization have
been designed that can identify population groups with the
potential for very high levels of resource consumption
[10,11], classify the types of patients attended, and expedite
costs forecasting.
At present, these are the best-validated risk adjustment
methods in the Spanish health context. The ACG® can be
used for more precise and equitable financial decision-
making and to evaluate the efficiency of health resource
utilization [12-14]. Analysis of risk-adjustment models
in Spain has included the calculation of measures of
efficiency. However, no published research to date has
assessed whether these indicators are representative of
the quality of care provided by PHC professionals (i.e.,
the effectiveness of the clinical practice). In health care
terms, effectiveness is the capacity to achieve a desired or
expected effect; efficiency is the capacity to achieve that ef-
fect with the minimum viable use of possible resources.
Measures of effectiveness in clinical practice derive from a
group of indicators defined by evidence-based medicine
and/or the various clinical practice guidelines [15-17].
The main objective of this study was to measure the
relationship between efficiency (as measured by cal-
culations based on three ACG® values) and effectiveness
(a set of process and outcomes indicators) in adult pa-
tients attended by PHCs in Catalonia (Spain).
Methods
Study design and population
A cross-sectional multi-centre study of computerized
medical records of outpatients and several population data-
bases was conducted in 2008 in Catalonia, a region in the
northwest of Spain with a population of 7.4 million [18].
The study population consisted of people of both sexes
attending 13 PHCs in Catalonia in 2008. Each PHC has
at least three (and an average of 12) basic care teams
(BCTs), defined as one general practice physician (GP)
and one nurse providing care for an assigned set of pa-
tients. Each patient is assigned to only one BCT, and the
GP is responsible for managing primary care services for
that patient, serving as the “gatekeeper” to the national
health system. There are four different health services
agencies, one of which administers six PHCs and the
others four, two, and one centre, respectively. These
PHCs have an assigned population of 284,013 inhabi-
tants aged >14 years (56.7% of these aged ≥65 years),
served by 187 BCTs. The population is characterized as
mainly urban, with a lower-middle socioeconomic level,
and predominantly engaged in industry, commerce and
services. All four agencies have a modern organization
structure, combining public management and private
provision of services by agreement with the Catalan HealthService. Policies on staffing, training levels, organization
and services offered are representative of most PHC cen-
tres in Catalonia, with decentralized management and cen-
tralized infrastructure. All of these PHCs use the same
electronic health record (EHR) software.
All patients aged >14 years seeking care during 2008
were included, a total study population of 196,593. Pa-
tients from other regions or countries, transferring out
to other centres or attended only by orthodontists dur-
ing the study period were excluded.
A visit was defined as any contact between a PHC
team and a patient seeking care due to a health problem,
whether in a PHC or at home. An episode was defined
as a process of care for a disease or condition or an ex-
plicit patient contact with health services and was coded
according to the International Classification of Primary
Care (ICPC)-2 [18]. Each episode occurring in the study
population was identified by the date it was recorded in
the EHR, whether acute or chronic and regardless of
when the diagnostic process began. Any one visit may
result in one or more diagnoses of a disease or condition
requiring care (episodes). On the other hand, one or
more visits may be required to resolve an episode and
to complete the patient’s contact with the BCT resulting
from the diagnosis.
Annual coverage (intensity of use) was defined as the
ratio of patients attended (196,593) with respect to the
assigned population of 284,013 (69.2%). A five-member
team (1 information retrieval officer, 2 clinical physi-
cians, 2 consulting technicians) coded the episodes and
diagnoses using ICPC-2, then mapped them to an ICD-
9-CM for ACG® analysis. The mapping criteria differed
according to whether the relationship between the codes
was null (one to none), univocal (one to one) or multiple
(one to several).
Patient and medical measures
Patient variables included age, sex, PHC, BCT, number
of visits, number of care episodes and total direct costs
of PHC care and co-morbidity.
Model of costs and use of resources
The design of the partial costs system was based on the
characteristics of the PHCs. The cost per patient attended
during the study period served as the unit of analysis for
the final calculation. This methodology is based on the re-
sources used in the visit (referrals, prescriptions, laboratory
tests) and indirect costs of a visit (facilities, administration,
personnel). The methodology used to calculate the costs
was published in the study protocol [14].
Measures of efficiency and complexity
Adjusted clinical groups (ACG®) were used to obtain three
indices of efficiency (EIs) and one index of complexity, or
Violán et al. BMC Health Services Research 2013, 13:421 Page 3 of 8
http://www.biomedcentral.com/1472-6963/13/421risk index (RI). The ACG® Grouper (version 8) functional
algorithm (http://acg.jhsph.org) is composed of a
series of consecutive steps that result in 106 ACG®, which
were mutually exclusive for each patient [7,8]. Construc-
tion of the ACG® required age, sex and diagnoses coded
according to ICD-9-CM [7,8,14].
Efficiency indices
Efficiency was evaluated by three indices:
a) costs EI: was calculated as the ratio of observed to
expected quantity costs.
b) visits EI: was calculated as the ratio of observed to
expected quantity of visits
c) episodes EI: was calculated as the ratio of observed
to expected quantity of episodes.
These three indices reflect the relative efficiency of
each centre or BCT. Expected episodes, visits and costs
were determined indirectly, based on the average num-
ber of visits, episodes or costs per patient in an ACG®
across all PHCs. The information required for this calcu-
lation is the number of visits per ACG® patient in the
total study population and the distribution of this refer-
ence population in each PHC or BCT to obtain the
“expected” numbers as indicated by the average for
the 13 PHCs.
The first step was to calculate for each PHC and for
each BCT the number of patient visits to be expected in
each ACG® if the standardized average number of visits
in the reference population for that ACG® is applied.
The number of patients in each ACG® category in each
PHC and BCT was multiplied by the average number of
visits in each category in the reference population. The
second step was to calculate the average visits per
assigned resident of the catchment area of each PHC
and BCT, obtained by dividing the observed number
of visits in each case by its assigned population. This
same calculation was used to establish the costs EI and
episodes EI.
Any EI value equal to one signifies efficiency equal to
the 2008 reference population standard, whereas EI <1
symbolizes greater efficiency (inverse relation).
Risk index (RI)
Defined by the ratio between average expected visits in a
PHC or BCT and average number of visits of the refer-
ence population [11], an RI value equal to one signified
a health complexity equal to the 2008 standard, whereas
an RI >1 represented greater complexity and <1 weaker
complexity. The RI reflected the complexity of cases
attended by a PHC or BCT with respect to the reference
population standard. The number of average expected
visits for each PHC or BCT was obtained indirectly, basedon the average number of visits of the total population in
each ACG group.
Measures of effectiveness
The synthetic index (SI) was obtained from a selection
of 20 primary care process and outcomes indicators de-
veloped by CatSalut (Catalan Health Service). Originally
obtained from the literature, the indicators were subse-
quently validated by an expert committee. These indicators
reflect current standards for procedures related to primary
and secondary prevention, diagnosis, treatment and patient
monitoring (Table 1). They address selected health ob-
jectives defined in the management contract between
CatSalut and agencies providing primary healthcare ser-
vices to the Catalan population [19]. For the implementa-
tion criteria, feasibility in the clinical setting was taken into
account. The scores for indicators obtained from EHRs
range from 1 to 100, reflecting a range from the lowest to
the highest effectiveness. For more detail about the indica-
tors and the construction of the SI, see Additional files 1
and 2, respectively.
Statistical analysis
All data were carefully reviewed before beginning the
statistical analysis, with researchers observing frequency
distributions and searching for possible errors in re-
cording or coding. Initial descriptive analysis of the results
was obtained by classifying patient sociodemographic and
clinical characteristics by PHC. Results were reported
using the mean and standard deviation or median and
interquartile rank for continuous variables and percent-
ages for categorical ones. Descriptive analysis of episodes,
total costs and visits for each ACG® reported the mean
and standard deviation; the ACG® distribution in each
PHC was described using absolute numbers and percent-
ages. The EI was calculated for episodes, costs, and visits,
each generating an index for comparative analysis; the RI
and general SI were calculated for each BCT and PHC.
The relationship between the EIs, RI and SI in each BCT
was measured by a multiple correlation coefficient (r).
Statistical significance was established as P = 0.05. The
analysis used SPSS v18, Stata/SE 11.0 for Windows, and
R version 2.10.1.
Ethics and clinical research
The study protocol was approved by the Committee on
the Ethics of Clinical Research of the Jordi Gol i Gurina
Foundation of the University Institute for Research in
Primary Care (Institut Universitari d’Investigació en
Atenció Primària Jordi Gol, IDIAP). Data were obtained
in electronic format and the confidentiality of records was
respected at all times according to Spanish law LO 15/
1999 13 December, Protection of personal data privacy
(Protección de Datos de Carácter Personal).
Table 1 Components of the general synthetic index (SI): definition of each indicator of process and results [19]
Indicator Description
1 Acceptable blood pressure control (<140/90 mm Hg, except in diabetes patients: <130/80 mm Hg.
2 Acceptable diabetes control, with a target of glycated haemoglobin (HbA1c) <7%
3 Blood pressure screening
4 Diabetes mellitus screening
5 Cardiovascular risk calculation in patients aged 35–74 years with total cholesterol >200 mg/dl
6 Alcohol consumption screening (adult population)
7 Ex-smokers, at one year
8 Ischemic heart disease patients with adequate antiplatelet treatment
9 Ischemic heart disease patients with low density lipoprotein <100 mg/ml
10 Cardiac arrhythmia patients with atrial fibrillation and anticoagulation treatment
11 Population >74 years attended and assigned, including home health care
12 Population >74 years attended and assigned, including home health care, with evaluation
13 Flu vaccine administered in the assigned population aged 60 years or more
14 Patients with chronic obstructive pulmonary disease and pneumococcal vaccine administered
15 Use of generic pharmaceutical specialties
16 Use of new medications with limited added value
17 Average cost per defined daily doses of proton pump inhibitors
18 Average cost per defined daily dose of statins
19 Average cost per defined daily dose of angiotensin-converting enzyme inhibitors (ACEI) and angiotensin II receptors antagonists (Angio II)
20 Average cost per defined daily dose of serotonin re-uptake inhibitors and new-generation antidepressants
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Description of population and variables
A total of 196,593 inhabitants were included in the ana-
lysis (69.2% coverage). Baseline characteristics of the 13
PHCs are presented in Table 2. The average age was
49.9 (standard deviation [SD] 19.9, range 45.5-53.0) and
56.7% were female (range 51.8%-60.0%). Three of the
PHCs had a median of 3.0 episodes per patient and 10
centres had a median of 4.0, with an Interquartile Rank
ranging from 2.0 to 7.0. The lowest average cost per pa-
tient was 527.2€ and the highest was 807.8€, with a
mean of 702.4€.
The distribution of ACG®, along with the average num-
ber of episodes, costs and visits for each ACG®, is presented
in Table 3. A total of 56 of the 106 defined ACG® were
present in 196,593 patients, with 5 corresponding to 44.5%
of the patients, 11 to 68.0% of patients, and 30 present in
less than 0.5% of the population.
Efficiency, risk and effectiveness in primary health centres
Efficiency, risk and effectiveness indices for each PHC
are described in Table 4. In six PHCs, all three EI results
(costs EI, visits EI, episodes EI) pointed in the same
direction (i.e., higher or lower than 1); the remaining
seven centres had differences between these ratios.
Costs EI ranged from 0.80 to 1.14, episodes EI from0.94 to 1.07 and visits EI from 0.89 to 1.23. Therefore,
the episodes variable differed the least between ex-
pected and observed data. The RI ranged from 0.89 to
1.09: the PHC population was 11% less complex than
the standard at the lower end of the range, and 9% more
complex at the upper end. The RI was greater than 1 in
seven centres and below 1 in four centres. Finally, the SI
ranged from 46% to 64%, with most of them between 53%
and 56%.
Relationship between efficiency, risk and effectiveness
for basic activity units
There was a moderate correlation between the costs EI
and visits EI (r = 0.59, P < 0.001) but only a weak correl-
ation between episodes EI and visits EI (r = 0.17, P = 0.021)
or costs EI (r = −0.12, P = 0.099). The correlation between
the RI and the other indices was significant only for the ep-
isodes EI. The correlations between SI and the EIs were
significant for episodes and cost (r = 0.48 and r = −0.34, re-
spectively) (Table 5).
Discussion
The episodes EI and costs EI calculated with the ACG®
system had an acceptable correlation with an indicator
of effectiveness (SI). Visits EI and costs EI also had ad-
equate correlations between them.
Table 2 Characteristics of patients attending family
medicine services
Assigned population, n 284,013
Attended population, n 196,593
Annual coverage (%) 69.2%
PHC Centres, n 13
BCT, n 187
Age in years 49.9 (19.9)
Attended population >65 years, n (%) 52,381 (26.6)
Attended females, n (%) 111,427 (56.7)
Number of episodes/patient 4.5 (3.3) ; 4 [2-6]
Number of visits/patient 7.8 (8.1) ; 5 [3-10]
Number of laboratory tests/patient 2.5 (3.4) ; 1 [0–4]
Number of radiographs/patient 1.2 (1.9) ; 0 [0–2]
Number of complementary tests/patient 0.2 (0.5) ; 0 [0–0]
Number of referrals to specialist/patient 0.7 (1.1) ; 0 [0–1]
Costs per patient, €
Visits 184.7 (191.2)
Laboratory tests 57.7 (76.7)
Radiographs 23.1 (35.5)
Complementary tests 7.0 (20.7)
Referrals to specialist 76.6 (121.0)
Pharmaceutical costs 353.4 (719.3)
Total Primary Health Care costs 702.4 (896.5)
Data are mean (standard deviation); median [IQR] unless otherwise indicated.
PHC: Primary Health Care Centre.
BCT: Basic care team.
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population from the perspective of the burden of mor-
bidity and resource utilization. This study analysed vari-
ous indicators used to assess resource utilization (i.e.,
efficiency and complexity), comparing them with a syn-
thesizing quality indicator used by primary care teams
in Catalonia. The EIs and RI permit a comparison of
care procedures between different PHCs and health care
professionals.
Defined clinical effectiveness indicators are useful to
compare the morbidity of a patient population and the
use of resources. Analysis of the RI allowed us to com-
pare population morbidity between centres. We observed
that some centres perform better on the effectiveness in-
dicator (SI) despite having a higher average complexity of
patient cases (RI). In the same manner, their costs are less
than other centres with similar morbidity, which indi-
cates that they make more efficient use of resources. The
SI indicator in these centres had high values, indicat-
ing good quality of care based on the defined indica-
tors. In this sense, if these results can be confirmed in
subsequent analysis, the ACG® system not only allowsappropriate resource allocation but also seems to be use-
ful in professional practice, contrary to the criticism re-
ceived that it could not assess how the work is being
performed [20].
In the analysis of correlations between BCTs for vari-
ous indicators, the visits EI and costs EI had good cor-
relation but there was poor correlation between the
episodes EI and visits EI. Although we have not found
reports in the literature that simultaneously calculate
these 3 indices of efficiency (episodes, visits and costs),
the differences we observed in the correlations between
them could perhaps be explained because the costs asso-
ciated with the ACG® were calculated on the basis of the
unit cost of the visit and not of the episode. This would
affect the results because an episode might involve mul-
tiple visits.
Continuing our analysis of correlation between the dif-
ferent BCTs, the RI and episodes EI were more highly
correlated than the visits EI or costs EI. As would be
expected, the RI was more correlated with episodes,
which constitute the morbidity load, and less with visits
and costs. This means that as multi-morbidity increases,
the health problems vary more widely from the average
and therefore there is no homogeneity with respect to
the development of the episodes of certain specific dis-
eases. Further studies are required to better explain and
interpret these correlations and variations between PHCs
and BCTs, including more information about type of PHC
(rural/urban) and the professional characteristics of general
practices [15-17].
One of the goals of our study was to analyse an effect-
iveness indicator, the SI. We observed a weak correlation
between the SI and the visits EI, indicating that centres
with good quality indicators do not necessarily achieve
them by increasing the number of visits.
There is a negative correlation between cost EI and SI.
However, it should be noted that we are comparing the
observed:expected cost ratio, rather than a direct cost
comparison between centres. Even so, these indicators
could be related to a predictor of clinical effectiveness:
increased cost represents decreased effectiveness in re-
source usage.
The last group of correlations analysed was between
the RI and the SI. The results show a trend towards cen-
tres with greater complexity and morbidity providing
high-quality patient care. These results also allow us to
identify and understand the resource utilization of some
PHCs and BCTs and help to provide better information
about the appropriateness of patient care provided. Ana-
lysis of each indicator by PHC and BCT showed that not
all physicians within the same PHC act in the same way,
and that the differences are related more to the phys-
ician than to the PHC. Nonetheless, it is well known that
physician behaviour depends to a great extent on the
Table 3 Characteristics of episodes, costs, visits and distribution of patients in each ACG®
Population Episodes Total costs Visits
ACG® code ACG® description n = 196,593 mean (SD) mean (SD) mean (SD)
4100 2-3 other ADG combinations, age 35+ 28,864 (14.7) 3.9 (1.3) 776.3 (828.2) 7.0 (5.2)
300 Acute minor, age 6+ 23,095 (11.7) 1.7 (0.9) 173.2 (249.8) 2.9 (2.6)
4910 6-9 other ADG combinations, age 35+, 0–1 major ADGs 14,876 (7.6) 10.2 (2.4) 1,624.4 (1,092.9) 17.4 (10.3)
4410 4-5 other ADG combinations, age 45+, no major ADGs 10,551 (5.4) 6.6 (1.6) 1,025.4 (755.9) 10.8 (6.2)
4420 4-5 other ADG combinations, age 45+, 1 major ADGs 10,137 (5.2) 6.7 (1.6) 1,336.2 (1,061.6) 12.2 (8.7)
2100 Acute minor/likely to recur, age 6+, w/o allergy 9,689 (4.9) 3.4 (1.4) 310.3 (296.3) 5.3 (3.8)
500 Likely to recur, w/o allergies 8,815 (4.5) 1.6 (0.8) 192.6 (274.4) 2.6 (2.3)
400 Acute major 7,511 (3.8) 1.6 (0.8) 243.2 (388.8) 3.0 (2.6)
1800 Acute minor/acute major 6,993 (3.5) 3.4 (1.3) 355.9 (393.2) 5.7 (4.0)
1600 Preventive/administrative 6,937 (3.5) 1.1 (0.3) 259.7 (540.2) 2.0 (2.2)
900 Chronic medical: stable 6,175 (3.1) 2.0 (0.7) 512.8 (580.5) 4.1 (3.3)
3900 2-3 other ADG combinations, males age 18 to 34 5,877 (2.9) 3.4 (1.0) 341.7 (399.1) 5.6 (4.1)
3200 Acute minor/acute major/likely to recur, age 12+, w/o allergy 5,535 (2.8) 5.4 (1.8) 529.0 (477.1) 8.1 (5.2)
2300 Acute minor/chronic medical: stable 5,345 (2.7) 3.7 (1.3) 634.8 (594.8) 6.8 (5.0)
3600 Acute minor/acute major/likely to recur/chronic medical: stable 5,300 (2.7) 7.8 (2.3) 1,043.4 (742.9) 12.4 (7.2)
4310 4-5 other ADG combinations, age 18 to 44, no major ADGs 4,168 (2.1) 5.9 (1.3) 554.8 (474.6) 9.3 (5.1)
4920 6-9 other ADG combinations, age 35+, 2 major ADGs 4,089 (2.0) 10.6 (2.5) 2,102.5 (1,407.8) 20.7 (13.9)
Other ACG® codes 32,636 (16.6) 5.0 (4.0) 747.8 (1,045.4) 9.0 (10.0)
Data are n (%) unless otherwise indicated.
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which affects variations in the pattern of health care ser-
vices provided [17,21-24].
The main limitation of our study is the data source
used. The EHR may have missing information or an
under-diagnosis bias; however, all PHCs use the sameTable 4 Efficiency, risk index and effectiveness for each prima
PHC1 PHC2 PHC3 PHC4 PHC
Efficiency indices
Expected costs/patient, € 733.65 752.71 728.61 686.39 707.0
Observed costs/patient, € 775.79 600.87 752.10 772.50 807.8
Cost efficiency index 1.06 0.80 1.03 1.13 1.14
Number expected episodes/patient 4.73 4.80 4.93 4.57 4.66
Number observed episodes/patient 4.61 4.88 5.09 4.59 4.93
Episodes efficiency index 0.98 1.02 1.03 1.00 1.06
Number expected visits/patient 8.17 8.33 8.49 7.85 8.02
Number observed visits/patient 8.93 8.56 9.04 9.05 9.87
Visits efficiency index 1.09 1.03 1.07 1.15 1.23
Risk index 1.05 1.07 1.09 1.00 1.03
Effectiveness index
Synthetic index 50.67 59.19 54.93 55.53 56.6
Expected data computed as indirectly standardized rates taking the total populatio
PHC: Primary Health Care Centre.software that requires entering a diagnosis at each visit.
Despite the potential limitations, the prevalence of mor-
bidity as estimated by EHR is substantially higher than
that reported by general population surveys, and similar
to that found in population-based longitudinal studies
[25]. In this sense, the use of indicators based on EHRry health care centre in the study
5 PHC6 PHC7 PHC8 PHC9 PHC10 PHC11 PHC12 PHC13
7 691.07 721.16 757.56 695.46 637.15 711.20 638.55 664.07
5 693.66 694.88 757.02 693.06 678.34 666.05 648.02 527.16
1.00 0.96 1.00 1.00 1.06 0.94 1.01 0.79
4.59 4.46 4.61 4.56 3.98 4.46 4.23 4.49
4.72 4.42 4.94 4.31 3.76 4.30 4.14 4.60
1.03 0.99 1.07 0.94 0.95 0.96 0.98 1.02
7.90 7.80 8.09 7.87 6.93 7.76 7.29 7.71
9.31 7.17 7.90 7.94 5.40 6.39 6.85 8.72
1.18 0.92 0.98 1.01 0.89 0.99 0.93 1.13
1.01 1.00 1.03 1.01 0.89 0.99 0.93 0.99
2 56.72 46.18 55.56 50.09 53.25 59.42 56.57 64.09
n as a standard population.
Table 5 Relationship between efficiency, risk and
effectiveness indices for 187 basic care teams*
Cost EI Episodes EI Risk index
Visits EI 0.59 (<0.0001) 0.17 (0.02)
Risk index −0.10 (0.16) 0.54 (<0.0001)
Synthetic index −0.34 (<0.0001) 0.48 (<0.0001) 0.29 (<0.0001)
*The relationship between indicators was measured by multiple correlation
coefficients (r).
In bold, significant values (P < 0.05). In parentheses, P value.
EI: Efficiency index.
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teristics be properly standardized, as well as those for re-
cording the number and values of study variables, if the
system is to be used to compare the efficiency and ef-
fectiveness of different PHC centres. Another potential
limitation of the study was the assessment of effective-
ness using the SI, an index constructed by the authors
for the purpose of this study that has not been tested in
other contexts; sensitivity and specificity of this index
were not assessed. However, we provide detailed criteria
for obtaining the SI values from standard EHR data
recorded in all primary care centres in Spain [19]. Spe-
cifically, the SI index was developed using a set of indi-
cators based on Clinical Practice Guidelines that were
validated by an expert panel.
Future studies are needed to replicate the data analysis
using other indicators of effectiveness that form part of
international clinical practice guidelines.
One of the strengths of the present study is the use of
the ACG® system developed for use in the United States
and used in Spain by numerous studies [6,7,26-30]. Specif-
ically, the ACG case-mix system was validated in Spain by
a 2005 retrospective, multi-centre study of 81,873 patients
[30] and in a Swedish community-based study [31]. The
ACG index (RI) used as an indicator of morbidity burden
was selected for two reasons: First, it is well established,
internationally validated, and well documented for use in
risk calculation [11,14]. Second, although many indicators
of morbidity burden are available (e.g., Aggregated Diag-
nosis Groups [ADG], Major ADG, ACG-related relative
weight), the RI would also establish the disease burden for
each BCT.
The absence of significant RI differences between
PHCs for selected diseases, confirmed by our analysis of
the distributions of the prevalence of the chronic dis-
eases included in the effectiveness indicators, allowed us
to make the efficiency and effectiveness comparisons that
were the primary aim of the study. Briefly, we sought to
determine whether the BCTs were responding to a similar
morbidity burden (RI) with any differences in efficiency
(cost EI, visits EI, episodes EI) or in the effectiveness indi-
cators (SI) routinely collected by the Catalan Health Ser-
vice. The ACG® were designed to measure health statusand health care resources consumed by specific groups
of individuals [9,10]. Therefore, future population-based
studies could be used to adjust risks of capitation and clin-
ical management of the centres.
This study defined various indicators of efficiency,
complexity and effectiveness that allowed the comparison
of the behaviours of numerous PHCs and BCTs. The re-
sults of this correlation analysis are complex to interpret
but permitted a comparison of PHCs effectiveness. Even
so, the indicators themselves are simple and easily
interpreted with the ACG® application. The use of these
efficiency, effectiveness and complexity indicators should
be explored in the context of assigning budget resources
to each PHC, based on the morbidity of their population,
to ensure that they have the needed care and quality
measures in place to meet the needs of each patient. In
these times of very tight budgets, budget adjustments
cannot be made without considering the morbidity pro-
file of the population attended by each PHC.
Conclusions
Indicators of efficiency, effectiveness and complexity using
ACG® permit a comparison of the care provided by differ-
ent primary care centres and health providers. The rela-
tionship observed between global efficiency indicators
related to episodes and costs permitted comparison of ef-
fectiveness between different PHCs. The complexity indi-
cator (RI) and the episodes EI were also adequately
correlated. The synthetic “effectiveness” indicator (SI) is
weakly correlated with the RI. The use of indicators based
on patient classification systems requires further study if
they are to be used for purposes of comparing activities
between different PHCs and health providers.
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